Key facts
- · Type: New offering first sale 2026-04-17 · Amount sold: $5M · Total offering: $5M · SEC filing
- · Type: New offering first sale 2026-02-19 · Amount sold: $5M · Total offering: $5M · SEC filing
- · Type: New offering first sale 2026-01-09 · Amount sold: $5M · Total offering: $5M · SEC filing
- · Type: New offering first sale 2025-12-27 · Amount sold: $5M · Total offering: $5M · SEC filing
- · Type: New offering first sale 2024-06-26 · Amount sold: $15M · Total offering: $15M · SEC filing
Is CASI Pharmaceuticals, Inc. a real, registered company?
CASI Pharmaceuticals, Inc. is a registered filer with the SEC (CIK 1962738) and has filed since 2024-07-15. 5 filings are on record, the latest on 2026-04-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Who runs CASI Pharmaceuticals, Inc.?
CASI Pharmaceuticals, Inc.'s filings name Alexander Wu, Chunhua Wang, Hai Huang and 11 more as its officers, directors or promoters.
How much has CASI Pharmaceuticals, Inc. raised?
Its new offerings report $35M sold across 5 offerings, as its own filings state.
Run the free check on CASI Pharmaceuticals, Inc. →
BEIJING, CHINA
2023
Pharmaceuticals
5
$35M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-04-28 | New offering first sale 2026-04-17 | $5M | $5M | details · SEC filing |
| 2026-02-26 | New offering first sale 2026-02-19 | $5M | $5M | details · SEC filing |
| 2026-01-28 | New offering first sale 2026-01-09 | $5M | $5M | details · SEC filing |
| 2026-01-28 | New offering first sale 2025-12-27 | $5M | $5M | details · SEC filing |
| 2024-07-15 | New offering first sale 2024-06-26 | $15M | $15M | SEC filing |
Want the whole picture on CASI Pharmaceuticals, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CASI Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CASI Pharmaceuticals, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from CASI Pharmaceuticals, Inc.'s own filings with the SEC. The people those filings name are on the team page.